Dexaméthasone

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire De Nantes, Nantes University Hospital

Conditions

Multiple MyelomaMultiple myeloma

Phase 2

A multi-center open-label phase 2 study of Ixazomib, Iberdomide and dexamethasone in elderly patients with multiple myeloma at first relapse

Not yet recruitingCTIS2024-516257-44-00

Centre Hospitalier Universitaire De NantesMultiple myeloma

Target: 80Updated: 2025-05-26

Phase 3

Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

CompletedNCT01971658

Nantes University HospitalMultiple Myeloma

Start: 2013-10-31End: 2015-08-31Updated: 2015-10-07

Related Papers

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma

Frontiers in Oncology2023-11-0216 citations